Dyne Therapeutics, Inc.Dyne Therapeutics, Inc.Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪4.07 B‬USD
−3.97USD
‪−235.94 M‬USD
‪68.32 M‬
Beta (1Y)
2.56

About Dyne Therapeutics, Inc.

CEO
John G. Cox
Headquarters
Waltham
Employees (FY)
141
Founded
2017
FIGI
BBG00NSGPJD0
Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of DYN is 43.76 USD — it has increased by 5.34% in the past 24 hours. Watch Dyne Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Dyne Therapeutics, Inc. stocks are traded under the ticker DYN.
DYN stock has risen by 25.96% compared to the previous week, the month change is a 32.41% rise, over the last year Dyne Therapeutics, Inc. has showed a 280.62% increase.
We've gathered analysts' opinions on Dyne Therapeutics, Inc. future price: according to them, DYN price has a max estimate of 56.00 USD and a min estimate of 41.00 USD. Watch DYN chart and read a more detailed Dyne Therapeutics, Inc. stock forecast: see what analysts think of Dyne Therapeutics, Inc. and suggest that you do with its stocks.
DYN reached its all-time high on Jul 12, 2024 with the price of 42.56 USD, and its all-time low was 4.30 USD and was reached on Jun 2, 2022. View more price dynamics on DYN chart.
See other stocks reaching their highest and lowest prices.
DYN stock is 7.63% volatile and has beta coefficient of 2.56. Track Dyne Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Dyne Therapeutics, Inc. there?
Today Dyne Therapeutics, Inc. has the market capitalization of ‪4.07 B‬, it has increased by 14.97% over the last week.
Yes, you can track Dyne Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Dyne Therapeutics, Inc. is going to release the next earnings report on Aug 1, 2024. Keep track of upcoming events with our Earnings Calendar.
DYN earnings for the last quarter are −0.81 USD per share, whereas the estimation was −0.80 USD resulting in a −1.25% surprise. The estimated earnings for the next quarter are −0.72 USD per share. See more details about Dyne Therapeutics, Inc. earnings.
Dyne Therapeutics, Inc. revenue for the last quarter amounts to 0 USD, despite the estimated figure of ‪1.67 M‬ USD. In the next quarter, revenue is expected to reach 0 USD.
DYN net income for the last quarter is ‪−65.65 M‬ USD, while the quarter before that showed ‪−66.64 M‬ USD of net income which accounts for 1.48% change. Track more Dyne Therapeutics, Inc. financial stats to get the full picture.
No, DYN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 15, 2024, the company has 141.00 employees. See our rating of the largest employees — is Dyne Therapeutics, Inc. on this list?
Like other stocks, DYN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Dyne Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Dyne Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Dyne Therapeutics, Inc. stock shows the strong buy signal. See more of Dyne Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.